REQUEST A DEMO
Total
USD $0.00
Search more companies

Dimidijus Pharm D.O.O. Beograd (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Dimidijus Pharm D.O.O. Beograd Profile Updated: September 30, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Dimidijus Pharm D.O.O. Beograd is an enterprise based in Serbia. Its main office is in Belgrade. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on March 20, 2001. It currently has a total number of 4 (2024) employees. The latest financial highlights indicate a net sales revenue increase of 2.8% in 2024. Its’ total assets recorded a negative growth of 7.65%. The net profit margin of Dimidijus Pharm D.O.O. Beograd increased by 0.08% in 2024.

Headquarters
Viline Vode bb
Belgrade; Belgrade;

Contact Details: Purchase the Dimidijus Pharm D.O.O. Beograd report to view the information.

Website: http://www.dimidiju.rs

Basic Information
Total Employees:
Purchase the Dimidijus Pharm D.O.O. Beograd report to view the information.
Registered Capital:
Purchase the Dimidijus Pharm D.O.O. Beograd report to view the information.
Financial Auditors:
Purchase the Dimidijus Pharm D.O.O. Beograd report to view the information.
Incorporation Date:
March 20, 2001
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Dimidijus Pharm D.O.O. Beograd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
2.8%
Total operating revenue
2.22%
Operating profit (EBIT)
-41.41%
EBITDA
-38.89%
Net Profit (Loss) for the Period
22.26%
Total Assets
-7.65%
Total Equity
0.72%
Operating Profit Margin (ROS)
-0.5%
Net Profit Margin
0.08%
Return on Equity (ROE)
0.23%
Debt/Equity
-5.09%
Quick Ratio
2.29%
Cash Ratio
0.59%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?